A Study in People With Systemic Sclerosis to Test Whether BI 685509 Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms A Study in People With Systemic Sclerosis to Test Whether BI 685509Has an Effect on Lung Function an ...
A Phase II, Randomised, Placebo-controlled, Double-blind, Parallel Group, Efficacy and Safety Study of at Least 48 Weeks of Oral BI 685509 Treatment in Adults With Early Progressive Diffuse Cutaneous Systemic Sclerosis A Phase II, Randomised, Placebo-controlled, Double-blind, Parallel Group, Efficacy and Safety Study ...